Company data
Mirum Pharmaceuticals, Inc. employees and revenue per employee
MIRM · Biotechnology · $5.24B market cap
Mirum Pharmaceuticals, Inc. had 369 employees at the end of fiscal Dec 2025, up 14.6% from a year earlier. Revenue for the year was $521M, up 54.7% from a year earlier, or $1.41M per employee. Revenue and headcount both grew, and revenue grew faster.
Employees
369
+14.6% YoY
Revenue
$521M
+54.7% YoY
Revenue / employee
$1.41M
Peer median $574K
Rank in industry
12 of 46
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 369 | $521M | $1.41M | +14.6% | +54.7% |
| Dec 2024 | 322 | $337M | $1.05M | +22.0% | +80.8% |
| Dec 2023 | 264 | $186M | $706K | +34.7% | +141.8% |
| Dec 2022 | 196 | $77.1M | $393K | +43.1% | +302.7% |
| Dec 2021 | 137 | $19.1M | $140K | — | — |
Open roles: we have not matched a verified job board for this company yet.
Mirum Pharmaceuticals, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| TGTX TG Therapeutics, Inc. | 399 | $616M | $1.54M | Efficient growth |
| MIRM Mirum Pharmaceuticals, Inc. | 369 | $521M | $1.41M | Efficient growth |
| KRYS Krystal Biotech, Inc. | 295 | $389M | $1.32M | Efficient growth |
| TVTX Travere Therapeutics, Inc. | 497 | $491M | $987K | Efficient growth |
| ADMA ADMA Biologics, Inc. | 647 | $510M | $789K | Leaner |
| AXSM Axsome Therapeutics, Inc. | 925 | $638M | $690K | Efficient growth |
| BBIO BridgeBio Pharma, Inc. | 834 | $502M | $602K | Efficient growth |
| TXG 10x Genomics, Inc. | 1,178 | $643M | $546K | Leaner |
| INSM Insmed Incorporated | 1,664 | $606M | $364K | Efficient growth |
Questions about Mirum Pharmaceuticals, Inc.
- How many employees does Mirum Pharmaceuticals, Inc. have?
- Mirum Pharmaceuticals, Inc. reported 369 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 25, 2026. That is up 14.6% from a year earlier.
- What is Mirum Pharmaceuticals, Inc.'s revenue per employee?
- Mirum Pharmaceuticals, Inc. brought in $521M of revenue in fiscal Dec 2025, which is $1.41M per employee. That ranks 12 of 46 companies we track in Biotechnology, where the median is $574K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare MIRM with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Mirum Pharmaceuticals, Inc.'s annual reports (Form 10-K), latest filed February 25, 2026. This is data, not a recommendation to buy or sell MIRM.